* Sanara Medtech Inc SMTI.OQ reported a quarterly adjusted
loss of 27 cents per share for the quarter ended in September.
The lone analyst forecast for the quarter was for a loss of 18
cents per share.
* Revenue was $5.82 million; analysts expected $6.30 million.
* Sanara Medtech Inc's reported EPS for the quarter was a loss
of 27 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Sanara Medtech Inc shares had fallen by 0.4% this quarter and
lost 31.6% so far this year.
* The company reported a quarterly loss of $2.02 million.
* Wall Street's median 12-month price target for Sanara Medtech
Inc is $45.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 12 at 10:46 p.m.
All figures in US dollars unless otherwise stated